Number of Subjects Who Seroconverted for Anti-human Papilloma Virus 16 (Anti-HPV-16) and Anti-human Papilloma Virus 18 (Anti-HPV-18) Antibodies At Month 7 [clinicaltrials_resource:a887edf1813e8b5871b750eb52a5a9b0]
Seroconversion is defined as the appearance of antibodies with titers greater than or equal to the predefined cut-off value in the serum of subjects seronegative before vaccination. Cut-off values assessed include 8 enzyme-linked immunosorbent assay units per milliliter (EL.U/mL) for anti-HPV-16 antibodies and 7 EL.U/mL for anti-HPV-18 antibodies.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Number of Subjects Who Seroconverted for Anti-human Papilloma Virus 16 (Anti-HPV-16) and Anti-human Papilloma Virus 18 (Anti-HPV-18) Antibodies At Month 7 [clinicaltrials_resource:a887edf1813e8b5871b750eb52a5a9b0]
Seroconversion is defined as the appearance of antibodies with titers greater than or equal to the predefined cut-off value in the serum of subjects seronegative before vaccination. Cut-off values assessed include 8 enzyme-linked immunosorbent assay units per milliliter (EL.U/mL) for anti-HPV-16 antibodies and 7 EL.U/mL for anti-HPV-18 antibodies.
Bio2RDF identifier
a887edf1813e8b5871b750eb52a5a9b0
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a887edf1813e8b5871b750eb52a5a9b0
measure [clinicaltrials_vocabulary:measure]
Number of Subjects Who Serocon ...... us 18 (Anti-HPV-18) Antibodies
time frame [clinicaltrials_vocabulary:time-frame]
At Month 7
description
Seroconversion is defined as t ...... mL for anti-HPV-18 antibodies.
identifier
clinicaltrials_resource:a887edf1813e8b5871b750eb52a5a9b0
title
Number of Subjects Who Serocon ...... -HPV-18) Antibodies At Month 7
@en
type
label
Number of Subjects Who Serocon ...... 7edf1813e8b5871b750eb52a5a9b0]
@en